TACROLIMUS
IMMUNOSUPPRESSANTS - CALCINEURIN INHIBITORS·PREVENTION OF KIDNEY TRANSPLANT REJECTION·+3
SANDOZ
Indication
Immunosuppression maintenance therapy for lung transplantation
Immunosuppression maintenance therapy for lung transplantation refers to the lifelong pharmacologic management of individuals who have undergone single, bilateral, or heart-lung transplantation. Read more about Immunosuppression maintenance therapy for lung transplantation
31 drugs 29 manufacturers
Drugs that treat it
Common Immunosuppression maintenance therapy for lung transplantation therapies.
PROGRAF (tacrolimus)
IMMUNOSUPPRESSANTS - CALCINEURIN INHIBITORS·PREVENTION OF KIDNEY TRANSPLANT REJECTION·+3
Astellas Pharma US
PROGRAF (tacrolimus)
IMMUNOSUPPRESSANTS - CALCINEURIN INHIBITORS·PREVENTION OF KIDNEY TRANSPLANT REJECTION·+3
Astellas Pharma US
TACROLIMUS
IMMUNOSUPPRESSANTS - CALCINEURIN INHIBITORS·PREVENTION OF KIDNEY TRANSPLANT REJECTION·+3
Mylan Pharmaceuticals
TACROLIMUS
IMMUNOSUPPRESSANTS - CALCINEURIN INHIBITORS·PREVENTION OF KIDNEY TRANSPLANT REJECTION·+3
DR.REDDY'S LAB
TACROLIMUS
PREVENTION OF KIDNEY TRANSPLANT REJECTION·+3
AHP
TACROLIMUS
IMMUNOSUPPRESSANTS - CALCINEURIN INHIBITORS·PREVENTION OF KIDNEY TRANSPLANT REJECTION·+3
MYLAN INSTITUTI
TACROLIMUS
PREVENTION OF KIDNEY TRANSPLANT REJECTION·+3
INGENUS PHARMAC
TACROLIMUS
PREVENTION OF KIDNEY TRANSPLANT REJECTION·+3
KREMERS URBAN
Filter & compare in the drug finder →Opens the drug finder with Immunosuppression maintenance therapy for lung transplantation preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonImmunosuppression maintenance therapy for lung transplantation refers to the lifelong pharmacologic management of individuals who have undergone single, bilateral, or heart-lung transplantation.
This post-transplant clinical state is characterized by constant vulnerability of the respiratory allograft to host immune recognition, driven by direct exposure of donor lung epithelial and vascular tissue to circulating host leukocytes and inhaled environmental antigens.
Without sustained immune modulation, recipient T-cell and antibody-mediated responses incite vascular and airway inflammation, culminating in acute cellular rejection, antibody-mediated rejection, or chronic lung allograft dysfunction.
Standard maintenance protocols continuously suppress lymphocyte activation and proliferation to preserve long-term graft survival and pulmonary gas exchange while balancing the competing risks of opportunistic infections and systemic toxicities.
- nih.gov
Immunosuppression maintenance therapy for lung transplantation refers to the lifelong pharmacologic management of individuals who have undergone single, bilateral, or heart-lung transplantation This post-transplant clinical state is characterized by constant vulnerability of the respiratory allograft to host immune recognition, driven by direct exposure of donor lung epithelial and vascular tissue to circulating host leukocytes and inhaled environmental antigens Standard maintenance protocols co...
- nih.gov
Immunosuppression maintenance therapy for lung transplantation refers to the lifelong pharmacologic management of individuals who have undergone single, bilateral, or heart-lung transplantation
- nih.gov
This post-transplant clinical state is characterized by constant vulnerability of the respiratory allograft to host immune recognition, driven by direct exposure of donor lung epithelial and vascular tissue to circulating host leukocytes and inhaled environmental antigens Without sustained immune modulation, recipient T-cell and antibody-mediated responses incite vascular and airway inflammation, culminating in acute cellular rejection, antibody-mediated rejection, or chronic lung allograft dysf...
- nih.gov
Without sustained immune modulation, recipient T-cell and antibody-mediated responses incite vascular and airway inflammation, culminating in acute cellular rejection, antibody-mediated rejection, or chronic lung allograft dysfunction
Personalize your experience
Follow Immunosuppression maintenance therapy for lung transplantation and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.